73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainPatients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than pati

Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainPatients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than pati
Scientists to improve cancer treatment effectiveness

Scientists to improve cancer treatment effectiveness

byNational Research Nuclear UniversityCredit: CC0 Public DomainTogether with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the N

Scientists to improve cancer treatment effectiveness

byNational Research Nuclear UniversityCredit: CC0 Public DomainTogether with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the N
Gene activation linked to severity of a rare lung cancer

Gene activation linked to severity of a rare lung cancer

byUniversity of CologneERT expression and telomerase activity in pulmonary carcinoids. Credit:Journal of Clinical Oncology(2024). DOI: 10.1200/JCO.23.02708Pulmonary carcinoids are ra

Gene activation linked to severity of a rare lung cancer

byUniversity of CologneERT expression and telomerase activity in pulmonary carcinoids. Credit:Journal of Clinical Oncology(2024). DOI: 10.1200/JCO.23.02708Pulmonary carcinoids are ra
Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA
A blood sample 24 hours after the start of chemotherapy can predict survival

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w
Ketamine therapy for mental health a 'Wild west' for doctors and patients

Ketamine therapy for mental health a 'Wild west' for doctors and patients

by Dawn Megli, KFF Health NewsOne 10 ml vial of 1000 mg ketamine. Credit: Psychonaught/WikipediaIn late 2022, Sarah Gutilla's treatment-resistant depression had grown so severe, she was actively c

Ketamine therapy for mental health a 'Wild west' for doctors and patients

by Dawn Megli, KFF Health NewsOne 10 ml vial of 1000 mg ketamine. Credit: Psychonaught/WikipediaIn late 2022, Sarah Gutilla's treatment-resistant depression had grown so severe, she was actively c
Breast cancer patients with government insurance at higher risk of death

Breast cancer patients with government insurance at higher risk of death

by ECOG-ACRIN Cancer Research GroupSamilia Obeng-Gyasi, MD (The Ohio State University) is the lead author on an analysis of the insurance status of 9800 breast cancer patients and their clinical outco

Breast cancer patients with government insurance at higher risk of death

by ECOG-ACRIN Cancer Research GroupSamilia Obeng-Gyasi, MD (The Ohio State University) is the lead author on an analysis of the insurance status of 9800 breast cancer patients and their clinical outco
Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma

Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma

by United European GastroenterologyCredit: Unsplash/CC0 Public DomainEating a Mediterranean diet rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunoth

Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma

by United European GastroenterologyCredit: Unsplash/CC0 Public DomainEating a Mediterranean diet rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunoth
Sleep disturbances are underappreciated in prostate cancer survivorship

Sleep disturbances are underappreciated in prostate cancer survivorship

by Tim Baker, Prostate Cancer Foundation of AustraliaCredit: CC0 Public DomainWe all got the memo that sleep is foundational for good health, right?Yet, it remains easy to overlook the importance of&n

Sleep disturbances are underappreciated in prostate cancer survivorship

by Tim Baker, Prostate Cancer Foundation of AustraliaCredit: CC0 Public DomainWe all got the memo that sleep is foundational for good health, right?Yet, it remains easy to overlook the importance of&n
Trial shows timing matters when adding immunotherapy to chemoradiation for limited-stage small cell lung cancer

Trial shows timing matters when adding immunotherapy to chemoradiation for limited-stage small cell lung cancer

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainPeople with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if bot

Trial shows timing matters when adding immunotherapy to chemoradiation for limited-stage small cell lung cancer

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainPeople with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if bot
Method that uses combination of immune cells could provide clearer prognoses

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-